Catalyst Wire Dossier Catalyst Wire Dossier

NNC0114-0006

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NNC0114-0006, covering 2014-04-08 to 2021-01-11. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function [Phase 2]

See pricing